Pharma

Premium

Healthcare

05 April, 2022

PAG to acquire over 20% in South-based pharma firm

Asia-focused private equity investor PAG is set to acquire at least 20% stake in Hyderabad-based bulk drug manufacturer Optimus Drugs ......

Economy

30 December, 2021

Indian shares end unchanged; tech, pharma stocks gain

Indian shares closed flat on Thursday, after moving in a narrow range through the day, with technology and pharma stocks ......

Manufacturing

21 December, 2021

Piramal Pharma invests $13 mn in Yapan Bio

Piramal Pharma Limited (PPL), on Tuesday, said that it has invested Rs 101.77 crore (around $13 million) in Hyderabad-based Yapan ......

Healthcare

11 March, 2021

Advent buys ZCL Chemicals, opens exit door for promoters and Morgan Stanley

Private equity firm Advent International has bought bulk drugs maker ZCL Chemicals for Rs 2,000 crore (around $275 million), offering ......

Insights Focus

13 January, 2021

Healthcare: The BIG Gap

The outbreak of the COVID-19 pandemic highlighted the huge supply-demand gap in the Indian healthcare ecosystem. The World Health Organization ......

Insights Focus

04 January, 2021

Watch Satish Chander, Partner, True North share crucial insights on healthcare through the investor lens 2020/ 21

At VCCircle’s flagship Healthcare Investment Summit 2020, Satish Chander, Partner, True North spoke with Shalil Gupta, Chief Business Officer, Mosaic ......

Healthcare

17 June, 2020

PE-backed Shilpa Medicare to acquire pharma firm, pick up 40% stake in another

Shilpa Medicare Ltd, a Hyderabad-based active pharmaceutical ingredients (APIs) and formulations developer, will acquire one pharmaceutical company and pick up ......

Healthcare

03 December, 2018

Sun Pharma shares tumble following report of regulatory probe

Shares of India’s Sun Pharmaceutical Industries sank more than 10 percent on Monday after a report of a regulatory probe ......

Healthcare

09 October, 2018

Chronic therapies to drive PE investments in pharma: IQVIA report

Chronic therapies and oncology in particular will be among the key drivers of private equity investments in the Indian pharmaceuticals ......

Finance

20 February, 2018

Teenage years for PE are over, Indian market has matured: Blackstone's Amit Dixit

Planned exits from private equity investments in India are no longer a major challenge, besides investors are also getting more ......